GlassScriptPhysician profile
Riya Vyas
NPI 1144803909
$4,981.30
in general payments reported to CMS, 2019-2025
8 companies · $396 in 2025
The $396 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $3,726 · 2023: $694 · 2024: $165 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Travel and Lodging: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.56 |
| Travel and Lodging | $376.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $2,455.34 | 2022-2024 | |
| Integra Lifesciences Corporation | $1,056.14 | 2022 | |
| Stryker Corporation | $842.29 | 2022-2024 | Variax, Citrefix, Viaflow |
| Treace Medical Concepts, INC. | $376.97 | 2025 | Tmc Speedmtp |
| Smith+Nephew, INC. | $200.71 | 2022-2023 | Collagenase Santyl, Evos, Panta 2 |
| Paratek Pharmaceuticals, INC. | $19.16 | 2025 | Nuzyra |
| Amgen INC. | $16.46 | 2024 | Krystexxa |
| Kci USA, INC. | $14.23 | 2023 | V.A.C. Dermatac, 3m Cavilon, V.A.C. Veraflo Cleanse Choice |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riya Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.